Gyöngyi Szabó

机构：Broad Institute, Beth Israel Deaconess Medical Center, Harvard University, University of Massachusetts Chan Medical School · ORCID：0000-0003-0836-2527

发表论文 503 篇 · 总被引 38182 次 · h-index 105

代表论文

• Immunological mechanisms and emerging therapeutic targets in alcohol-associated liver disease (2025 · Cellular and Molecular Immunology · 被引 32)
• Metabolic dysfunction and alcohol-associated liver disease (MetALD) (2025 · eGastroenterology · 被引 21)
• Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease (2025 · Nature Reviews Gastroenterology & Hepatology · 被引 20)
• Natural history and development of a novel composite endpoint in patients with alcohol-associated hepatitis: Data from a prospective multicenter study (2025 · Hepatology · 被引 9)
• Ethanol consumption aggravates amyloid pathology and neuroinflammation in Alzheimer’s disease associated with inflammasome activation and ASC speck propagation (2025 · Journal of Neuroinflammation · 被引 7)
• Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials (2026 · The Lancet · 被引 5)